Author: Suzuki, Shigeaki
Title: Significance of anti-striational antibodies for immune checkpoint inhibitor-related myositis: a comment on the article by Aldrich et al. Cord-id: 4kx090zu Document date: 2021_3_7
ID: 4kx090zu
Snippet: Aldrich et al. clearly described the clinical features of immune checkpoint inhibitor-related myositis (ICI-myositis) divided by the presence or absence of myasthenia gravis (MG) (1). From the viewpoint of a neurologist, I emphasize that making a diagnosis of MG that has occurred as immune-related adverse event is difficult when anti-acetylcholine receptor (AChR) antibodies are undetectable.
Document: Aldrich et al. clearly described the clinical features of immune checkpoint inhibitor-related myositis (ICI-myositis) divided by the presence or absence of myasthenia gravis (MG) (1). From the viewpoint of a neurologist, I emphasize that making a diagnosis of MG that has occurred as immune-related adverse event is difficult when anti-acetylcholine receptor (AChR) antibodies are undetectable.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date